1 completed, 1 not yet recruiting, 1 terminated. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Cynthia McEvoy: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| eCPAP Follow-up at School Age Extended CPAP (eCPAP) - Lung Function | Not yet recruiting | Cynthia McEvoy | 95 | 2026-10-01 | 2026-10-08 | |
| Extending CPAP Therapy in Stable Preterm Infants to Increase Lung Growth and Function Additional 2 weeks of CPAP - Neonatal, Premature Birth | Not applicable | Completed | Cynthia McEvoy | 100 | 2020-01-10 | 2025-08-17 |
| Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial Budesonide in Calfactant - Bronchopulmonary Dysplasia (BPD) | Phase 1 / Phase 2 | Terminated | Cynthia McEvoy | 25 | 2016-09-01 | 2025-04-04 |
Premature Birth (2) · Bronchopulmonary Dysplasia (1) · Respiratory Distress Syndrome (1)
Budesonide (1) · calfactant (1)
United States (2)
Cindy McEvoy, MD (1)
PMID 32006953, PMID 39977011, PMID 42190903
R01HL184382 (1), R33HL147906 (1)